News

Advancing Early Detection of Fetal Anomalies with Detailed First-Trimester Ultrasound

By Brian K. Iriye, MD; Vanita D. Jain, MD; and Anthony C. Sciscione, DO What is DFTU and Why Is It Important? The Detailed First-Trimester Ultrasound (DFTU) is a high-resolution scan performed between weeks 12 and 13 of pregnancy to detect fetal structural anomalies.1 It is indicated for... Continue Reading

Nuchal Translucency Credentialing & Coding

Authors: The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Steve Rad, MD, FACOG; Brad Hart, MBA, MS, CPC, CPMA, COBGC; Vanita Jain, MD, FACOG. Background: First trimester screening includes biochemical markers, fetal nuchal translucency (NT) assessment via ultrasound (CPT 76813;... Continue Reading

Coding for Placenta Accreta Spectrum

Placenta accreta is defined as an abnormal invasion of all or part of the placenta into the myometrial wall of the uterus. Placenta accreta spectrum (PAS) is the more current terminology to refer to the range of abnormal placental invasion that includes placenta accreta, increta and percreta. ... Continue Reading

Billing of 76801 and/or 76813 with cfDNA screening

Cell-free fetal DNA (cfDNA) screening has enhanced the ability to offer early aneuploidy screeningin pregnancy. The purpose of this White Paper is to describe billing recommendations when cfDNAscreening is done or considered in conjunction with first trimester Nuchal Translucency screening(CPT... Continue Reading